Language selection

Search

Patent 2001087 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2001087
(54) English Title: PROCESS FOR THE PREPARATION OF 4-O-ALKYLRHODOMYCINS
(54) French Title: PROCEDE DE PREPARATION DE 4-0-ALKYLRHODOMYCINES
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07C 50/36 (2006.01)
  • C07C 69/12 (2006.01)
  • C07F 07/18 (2006.01)
  • C07H 15/252 (2006.01)
(72) Inventors :
  • KOLAR, CENEK (Germany)
(73) Owners :
  • BEHRINGWERKE AKTIENGESELLSCHAFT
(71) Applicants :
  • BEHRINGWERKE AKTIENGESELLSCHAFT (Germany)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1989-10-20
(41) Open to Public Inspection: 1990-04-22
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
P 38 36 122.1 (Germany) 1988-10-22

Abstracts

English Abstract


BEHRINGWERKE ARTIENGESELLSCHAFT 88/B 031 - Ma 724
Dr. Ha/Li/Hch
Abstract of the disclosure
Process for the preparation of 4-O-alkylrhodomycins
A process is descried for the preparation of 4-O-alkyl-
rhodomycins of the formula I
<IMG>
I
in which
R1 denotes H, C1-C4-alkyl or an acyl protective group,
R2 denotes OH, COOCH3, O-Si(C1-C4-alkyl)3 or an O-acyl
protective group, acyl being acetyl, monohalogeno-
acetyl, dihalogenoacetyl or trihalogenoacetyl with
fluorine or chlorine as the halogen, benzoyl or p-
nitrobenzoyl,
R3 denotes C1-C4-alkyl,
R4 denotes H or
R4 and R5 togethex denote a tetraisopropyldisiloxane-
1,3-diyl protective group, and
R5 denotes H or a glycosyl radical of the fonmula II
<IMG> II
in which
R6 is OH, acetoxy, NHCOCF3, NH2, a mono-C1-C4-alkylamino
group or a di-C1-C4-alkylamino group or a 4-morpho-
linyl group and
R7 is H, OH or an acetoxy, trifluoroacetoxy or p-
nitrobenzoyloxy group,
and the use thereof for the preparation of 7-O-glycosyl-

- 2 -
rhodomycins which are suitable, by virtue of their
cytostatic activity for the treatment of oncoses.


Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the preparation of a rhodomycin derivative
of the formula I
I
<IMG>
in which
R1 denotes H, C1-C4-alkyl or an acyl protective group,
R2 denotes OH, COOCH3, O-Si(C1-C4-alkyl)3 or an O-acyl
protective group, acyl being acetyl, monohslogeno-
acetyl, dihalogenoacetyl or trihalogenoacetyl with
fluorine or chlorine as the halogen, benzoyl or p-
nitrobenzoyl,
R3 denotes C1-C4-alkyl,
R4 denotes H or
R4 and R5 together denote a tetraisopropyldisiloxane-
1,3-diyl protective group, and
R5 denotes H or a glycosyl radical of the formula II
<IMG>
II
in which
R6 is OH, ac toxy, NHCOCF3, NH2, a mono-C1-C4-alkylamino
group or a di-C1-C4-alkylamino group or a 4-morpho-
linyl group and
R7 is H, OH or an acetoxy, trifluoroacetoxy or p-
nitrobenzoyloxy group,
which comprises reacting a rhodomycinone derivative of
the formula I in which
R1 is H,
R2 is OH or COOCH3 and
R3, R4 and R5 are H,
with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane and,
if appropriate, subsequently with a tri-C1-C4-alkylsilyl

halide, preferably with a chloride derivative, in the
presence of a base, such as pyridine or dimethylamino-
pyridine, and an organic solvent, such as methylene
dichloride or chloroform, at a temperature between 15°C
and 80°C to give a 6,7-O-(tetraisopropyldisiloxane-1,3-
diyl)-rhodomycinone compound of the formula I in which
R1 and R3 are H,
R2 is COOCH3 or O-Si(C1-C4-alkyl)3 and
R4 and R5 together are a tetraisopropyldisiloxane-1,3-diyl
group,
then etherifying the resulting compound with an alkylat-
ing agent, preferably a C1-C4-alkyl bromide or iodide, in
the presence of an alkali metal carbonate and an organic
solvent, such a acetone or dioxane, at the phenolic
hydroxyl group on the C-4 atom, if appropriate also at
the phenolic hydroxyl group on the C-11 atom, then, if
appropriate, splitting off the trialkylsilyl protective
group at the C-10 atom by acid hydrolysis, preferably by
means of hydrochloric acid, and acylating the resulting
compound at the 10-hydroxyl group and, if appropriate, at
the 11-hydroxyl group by means of an acylating agent,
preferably p-nitrobenzoyl chloride, trifluoroacetic
anhydride or acetyl chloride, in the presence of a base,
such as pyridine, triethylamine or dimethylaminopyridine,
and an organic solvent, such as methylene dichloride or
chloroform, and splitting off the tetraisopropyldisil-
oxane-1,3-diyl group by means of an ammonium fluoride,
preferably tetrabutylammonium fluoride, in a polar
organic solvent, such as tetrahydrfuran or dioxane, in
the course of which a compound of the formula III
III
<IMG>
III
in which
R1 denotes H, C1-C4 alkyl or an acyl protective group
indicated above,
R2 denotes COOCH3 or an O-acyl protective group and

R3 denotes C1-C4-alkyl is formed.
2. The process as claimed in claim 1 for the preparation of
a .beta.-rhodomycinone derivative of the formula I in which
R1 is H or C1-C4-alkyl,
R2 is OH or an O-acyl protective group,
R3 is C1-C4-alkyl and
R4 and R5 are H.
3. The process as claimed in claim 1 for the preparation of
an epsilon-rhodomycinone derivative of the formula I in
which
R1 is H,
R2 is COOMe,
R3 is C1-C4-alkyl and
R4 and R5 are H.
4. The use of a rhodomycinone compound of the formula III
for the preparation of a 7-O-glycosyl-rhodomycinone
compound of the formula I, which comprises reacting a
compound of the formula III in a marner known per se with
a functionalized deoxy-sugar of the formula IV or V,
<IMG> IV <IMG> V
in which
R6 reprsents an acetoxy or trifluoroacetamido group,
R7 represents a hydrogen atom or an acetoxy, trifluoro-
acetoxy or p-nitrobenzoyloxy group and
Y represents an acetoxy or p-nitrobenzoyloxy group or
a chloride, in the presence of a catalyst, such as
a tri-C1-C4-alkylylsilyl trif1uoromathaneaulfonate or
the silver salt of trifluoromethanesulfonic acid, to
give a 7-O-glycosylrhodomycinone of the formula I in
which the radicals R1, R2, R3, R6 and R7 retain the
meanLng defined in formulae III, IV and V, then
splitting off the acyl protective groups by alkaline
hydrolysis, in the course of which a compound of the
formula I in which

R1 denotes H or C1-C4-alkyl
R2 denotes OH or COOCH3,
R3 denotes C1-C4-alkyl,
R4 denotes H and
R5 denotes a glycosyl radical of the formula II in
which
R6 is NE2 or OH and
R7 is H or OH is formed,
and, if appropriate, reacting a resulting compound of the
fommula I containing an amino-sugar under the conditions
of reductive alkylation with a C1-C4-aldehyde or diglycol
alciehyde ln the presence of an alkali metal cyanoborohyd-
ride to give a further compound of the formula I in which
the radicalçi R1, R2, R3, R4, R5 and R7 retain the last
mentioned meaning and R6 represents a mono-C1-C4-alkyl-
amino or di-C1-C4-alkylamino group or a 4-morpholinyl
group.
5. The use of a .beta.-rhodomycinone compound as claimed in claim
2 for the preparation of a 7-O-glycosyl-,.beta.-rhodomycinone
compound of the formula I in which
R1 denotes H, C1-C4-alkyl or an acyl protective group,
R2 denotes OH or an acyl protective group,
R3 denotes C1-C4-alkyl,
R4 denotes H and
R5 denotes a glycosyl radical of the formula II in
which
R5 is OH, acetoxy, NHCOCF3, NH2, a mono-C1-C4-alkylamino
group or a di-C1-C4-alkylamino group or a 4-morpho-
linyl group and
R7 is H, OH or an acetoxy, trifluoroacetoxy or p-
nitrobenzoyloxy group.
6. The use of an epsilon-rhodomycinone compound as claimed
in claim 3 for the preparation of a 7-O-glycosyl-epsilon
rhodomycinone compound of the formula I in which
R1 denotes H or C1-C4,-alkyl,
R2 denotes COOMe,
R3 denotes C1-C4-alkyl,

R4 denotes H and
R5 denotes a glycosyl radical of the formula II in
which
R6 is OH, acetoxy, NHCOCF3, NH2 or a mono-C2-C4-alkyl-
amino group or di-C1-C4-alkylamino group or a 4-
morpholinyl group and
R7 is H, OH or an acetoxy, trifluoroacetoxy or p-
nitrobenzoyloxy group.

7. The process as claimed in claim 1, and substantially as
described herein.

Description

Note: Descriptions are shown in the official language in which they were submitted.


BEHRINGWERKE ARTIENGESELLSCHAFT 88/B 031 - ~a 724
Dr. Ha/Li./Hch
Process for the preparation of 4-O-alkylrhodomycins
The present invention relates to a new process for the
preparation of 4-O-alkylrhodomycins, e~pecially 4-O-
alkyl-~-rhodomycinone~ and 4-O-alkyl epsilon-rhodomycin-
ones, and the use th~reof for the preparation of 7-O-
glycosylrhodomycins which, by virtue oP their cytostaticeffectiveness, ~re suitable for the treatmen~ of oncoses.
Anthracyclins are described in the ~pecialist literature.
It is known from the doxorubicin-daunorubicin group of
anthracyclin that 4-O-methyl ~ubstitution is necessary
in the anthracyclins for antitumoral action and tumor
~electivity. The corre~ponding 4-hydroxy derivativeæ,
~uc~ as carminomycins and ~-rhodomycins, are cytotoxic
and les~ tumor-selective.
The invention i~ based on the ob~ect of developing a
proce~s which gives 4-O-alkylrhodom~rcinone derivatives in
good yield~ and which means a s~nplifi~ation co~pared
with ~he known process, as well a~ the elaboration of a
protective group chemi~try on 4-O alkylrhodomycinones
whi~h make6 it pos~ible to u~e the aglycone for the
preparation of 7-O-glycosylrhodomycinones.
The present proce~s for the preparation of 4-O-alkyl-
rhodomycin~ i~ based on the surpxising findin~ that an
unprotected rhodcmycino~e aglycone can be reacted with
1,3-dichloro-1,1,3 9 3-tetrai~opropyldi6iloxane to ~ive a
6,7-O-(tetraisopropyldisiloxane-1,3 diyl)~rhodomycinone
and then with a trialkylsilyl halide to g~ve ~ 10-O-
trialkyl~ilyl compound. By thi6 route th~ ~ubseguent
alkylation can only t~ke place at the phenoli~ hydroxyl
group~ at the C-4 and C~ tom~ alkylation of the
phenolic group at the C-4 atom curpri~ingly is mainly
taking place.

- 2
Thi~ ob~ect is achieved in ~ccordance with the invention
by the proces~ for the preparation of a rhodomycin
derivative of the formula I
O ORl R
~ ~ E~ I
R30 D OR~ b R 3
in which
R~ denotes ~, C~-C4-alkyl or an acyl protecti~e group,
R2 denotes OH, COOCH3, O-Si(Cl-C4-alkyl)3 or an O~acyl
protective gxoup, acyl being acetyl, monohalogeno-
acetyl, dihalosenoac0tyl or trihalogenoacetyl with
fluorine or chlorine a6 the halogen, benzoyl or p-
nitroben~oyl,
R3 deno~e~ Cl-C4-alkyl,
R4 denotes H or
R4 and R5 together denote a tetrai~opropyldisiloxane-
1,3-diyl protective group, and
Rs denote H or a glycosyl radical of the formula II
R7 ~ ~
R~ ;
in which
R6 i8 OH, ~etoxy, ~HCOCF3, NHz, a mono-C~-C~-alkylamino
~roup or a di-Cl-C~-alkylEmino group or a 4-morpho-
linyl group and
R7 1~ H9 OH or an acetoxy, trifluoroaceto~y or p-
nitrobenzoylo~y group,
which compri~e6 reactin~ a rhodomycinone derivati~e of
the formula I in which
R2 is OH or COOCH3 ~nd
R3, R~ and R5 ~re H,
with 1,3Ydichloro-1,1,3,3-tetraisopropyldisiloxane a~d,
if appropriate, ~ubsequen~ly with a tri-C,-C~alkyl~ilyl
halide, pxeferably with a chloride deriv~tive, in the
,,
,~ , ,

8~7
-- 3 --
presence of a b~se, ~uch as pyricline or dimethylamino-
pyridine, and an organic ~olvent, 6uch as methylene
dichloride or chloroform, at a tempera ure between 15C
and 80C to give a 6,7 0-(tetrai~opropyldi~iloxans-1,3-
diyl)-rhodomycinone compound of the formula I in which
R1 and R3 are H,
R2 is COOCH3 or O-Si(Cl-C4-alkyl) 3 and
R4 and R5 together are a tetrai~opropyldi~iloxane-1/3-diyl
group,
then etherifying th~ resultin~ compound with an al~ylat-
ing agent, pxeferably a Cl-C4-alkyl bromide or iodide, in
the presence of an alkali metal carbonat~ and an organic
601vent, such a ace$onP or dioxa~e, at the phenolic
hydroxyl group on the C-4 a~om, if appropriate al~o at
the phenolic hydkoxyl group on the C-11 atom, then, if
appropriate, ~plitting off the trialkyl~ilyl protective
group st the C-10 atom by acid hydrolysis, preferably by
means of hyckochloric acid, and acylating the resulting
compound at the 10-hydroxyl group and, if appropriate, at
the ll hydroxyl group by means of an acylating agent,
preferably p-nitxobenzoyl chloride, tri~luoroacetic
anhydride or ~cetyl chloride, in the pre~ence of a ba~e,
~uch as pyridine, triethylamine or dimethylaminopyridine,
and an organic 501vent ~ ~uch as methylene dichloride or
chloroform, and ~plitting off the tetrai~opropyldi~
o~ne 1,3-diyl group by means of an ammonium fluoride,
preferably tetr~butylammonium fluoride, in a polar
organic solvent~ ~uch as tetrahydrofuran or dioxane, in
the course of which a compound of the formula III
O ORI R2
~ Jo~ III
R30 HO OH
in which
Rl denote~ ~, Cl C4-alkyl or an acyl protective group
~ndicated above,
R2 denotes COOCH3 or an O acyl protective group and
R3 denotes C,~C4~alkyl i8 formed. .

-- 4 --
The proce~s on which ~he inven~ion i~ based i~ illus-
trated in Scheme 1.
The use of a rhodomycinone compound of the formula III in
a proce6s for the praparation of a 7-0-sl~cos~ rhodomyci-
ncne compound of th~ forMula I compri6es reacting acompound of the formula III in a manner known per 6e with
a functionalized deoxy ~ugar of the formula IV or V
R 1
R6 R6
in which
R6 represents an acetoxy or trifluoroacetamido group,
R7 repre~ents a hydrogen atom or an acetoxy~ trifluoro-
ace~o~y or p-nitrobenzoyloxy group and
Y repre~ents an acetoxy or p-nitrobenzoyloxy group or
8 chloride, in the presence o:E a catalyst, such as
a tri-C~-C4-alkyl ilyl trifluoromethanesulfonate or
the ~ilver ~alt of trifluoromethane6ulfonic acid, to
give a 7-0-glycosyl-rhDdomycinone of the formula I in
which the radical~ Rl, R2, R3, R6 and R7 retain the
meaning defined in formulae III, IV and V, then
spli~ting off the acyl protect.ive groups by alkaline
hydroly~i~, in the course of which a compound of the
formula I in whieh
R1 denotes H or Cl-C4-~lkyl,
RZ denote6 OH or COOCH3,
~5 ~3 denotes Cl-C4-alkyl,
R~ denotes H and
R5 denotes a glyco~yl radical of the formula II in
which
R6 i~ ~H2 or OH and
R7 is H or OH i8 fonmed,
and, if appropriate, reacting a re~ulting compound of the
formula I containing an amino-~ugar under the conditions
of reductive alkylation with a C~-C~-aldehyde or diglycol
aldehyde in the presence of an alkali metal cyano-

borohydride to ~ive a further compound of the formulil I
iLn which
.
... , .,. ~ . ,
.,: ';!. ..
, ~ .: .
';, ' -' ~ , :
': .. : ~, .: ,

Scheme 1
~f Et -~~~ OH
6 , ~ r 1 d I~CH z Cl ;~ 6 7
-RMN ~ 5 ~ _ O_
/~
./ Me 3 SiCJ
~e .-~ pyrldine ~1~
rle-Si-~e ~le-Si-Me
OHO O O R10 O
Mel/ I~a2CO~ 0H
OH O 9 o ~e~D~C~ 2CI 2rqeO O O O
~si-o-sj <~ ~Si-O-Si~
CH 2Cl 2~,/"'/ [~ ~3
q ~J " O H O H O O - p N O z
neo o o o Butq~llF~THF ~ ~ = Et
~Si--o--si~ 6 ~7
~ 1eO O HO OH
pNBzCI I R = H ¦ :
yr/C~I 2Ct z C ¦ R2 = pNBZ ¦
pNBz = p 02N-PtlCO-

%~
-- 7 --
the radicals R1, R2, R3, R4, R5 and R7 retain the last-
mentioned meaning and RB represents a mono-Cl-C4-alkyl-
amino or di-Cl C4-alkylamino group or 8 4-morpholinyl
group.
S Example6
The present invention is described in greater detail in
the following e~ampl~s, without being limited thereto.
~he ~tructure o the compounds described in the following
examples was determined by means of NMR and M~ analytical
chemistry. ~he progre~ of the reactivns and the chemical
purity of the compounds were investigated by thin layer
chromatography or by EPLC.
~xample 1
The introduction of silyl protective groups into a
rhodomycinone in po~itions 6,7 ~nd, if appropriate, 10.
6,7-0-(1,1,3,3-Tetraisopropyldisiloxane-1,3-diyl)-~-
rhodomycinone
~Compound 1)
10 g (25.8 mmol) of ~-rhodomycinone were di~solved in
300 ml of 1:1 pyridine/methylene dichloride, and 1202 ml
(1.5 equivalents) of 1,3-dichloro~1,1,3,3-tetrai~opropyl-
d~iloxane, dis olved in 150 ml of methylene dichloride,
were added at 0C with the exclusion of moisture. ~he
re~ction mixture wa~ ~tirred for 24 hour~ Bt xoom tem-
perature and then for a further 72 hour~ at 60C. After
the further addition of 6.5 ml (O.8 equivalent~) of 1,3-
dichloro-1,1,3,3-tetraisopropyldi~iloxane, the reaction
mixture was ~tirred for a further 72 hours ~t 60~Co 50 ml
of methanol were added to the reaction ~i~ture ~nd the
product wa~ ev~poratPd in vacuo and ~ubject~d to two
further di~tillation~ with toluene. The re~idue which
remained was purified by column chromatography t~ilica
gel; mobile phase: 20sl chloroform/ethyl acetate)~
,
' '~

- 8 -
Yield: 10.8 g (67%); meltin~ point. 115-117C
~alpha~D = ~425 (C = 0.2 in chloroform)
~H-NMR (90 ~Hz, CDCl3, delta~: 13.91 and 13.07 (~,PhOH),
7.82 (br d, H-l), 7.65 (t, H-2), 7.30 (br d, H-3), 5.28
S (br 6, H-7), 4.9S (8, H-10), 4.75 (6, 9-OH)~ 3.66-3.54
(m, alkyl-Si3
6,7-0-(1 t 1,3,3~Tetrai~opropyldi6iloxane-1,3-diyl)-ep~i-
lon-rhodomycinone
(Compound 2)
5 g (11.67 mmol) of epsilon-rhodomycinone a~d 9.2 g ~2~5
equivalents) of 1,3-dichloro-1,1,3,3-tetrai~opropyl
disiloxane were dissol~ed in 150 ml of 1:1 methylene
dichloride/pyTidine. After a reaction time of 8 day~ the
title compound wa~ i~olated a de~cribed in the in~truc-
tions for ~he preparation of compound 1.
Yield: 6.1 g (78~)
6 t 7-0-~1,1,3,3-Tetraisopropyldi6iloxane~1,3-diyl)-10-O-
trimethylsilyl-~-rhodomycinone
(Compound 3)
19.0 g (30.2 mmol) of compound 1 were di~solved in 250 ml
of methylene dichloride a~d 250 ml of pyridine, and 4.2 g
~1.5 equivalents) o~ chlorotrimethylsilane t di~olved in
50 ml of methylene dichloride, we:re added at 0C. The
reaction mixture was ~tirred for 1 hour at room tempera~
ture. The r~sction mixture wa~ then evaporated in vacuo
and sub~ected to two further distillation6 ~ith toluene.
The residue wa~ puri~ied by column chromatography (silica
gel; mobile phase: 7:3 methylene dichloride/petrol~um
ether),
Yield: 1~.3 g (77~); ~elting points 194-196C
(alpha)D - +530~ (c = 0.2 in chloroform)
H-NMR (300 ~Hz, CDCl3, delt~): 13.87 and 13.12 t~, phOH),
7.79 ~dd, ~-1), 7.61 (t, H-~), 7.25 (dd, H-3), 5.23 ~dd,
~-7), 2.13 (dd, H-8~ .06 (dd, H-8b), 4.86 (br ~, H-
10), 1.64 (m, H-13a and H-13b), 1002 (t, H-14), 0.2 and
1.2-1.3 (m, alkyl-Si)

-- 9 -
Example 2
Alkylation of a rhodomycinone in po~ition 4 or, if
appropriate, 11.
4-0-Methyl-6,7-0-(1,1,3,3-~etraisopropyldisiloxane 1,3-
diyl)-10-0-trimethylsilyl-~rhodomycinone
(Compound 4) and
4,11-Di-0 methyl-6,7~0-(1,1,3,3-tetraisopropyldi~iloxane-
1,3-diyl)-10-O-trimethyl6ilyl-~-rhodomycinone
(Compound 5)
10 Process a):
0.75 g (1.07 mmol) of compound 3 were di~solved in 30 ml
of acetone and 7 ml of methylene dichloride~ and 4.4 g
(30 equivalent~) of pota~sium carbonste and 10 ml ~150
equivalent~ Qf methyl io~ide were added. The reaction
15 mixture wa~ ~tirred for 3 day6 at room temperature, the
progres~ of the xeaction being followed by thin layer
chromatography. Methylene dichloride wa~ added to the
reaction mixture and the product was extracted by w~shing
succes~ively with water, 1 N hydrochlori~ acid and water.
20 The organic phase was dried over sodium sula~e and
evaporated in ~acuo. The ~ompounds 6 and 7, ~hich were
present in the residue, were ~eparated by column chroma-
tography over 35 g of ~ilica gel u~i.n~ methylene dichlor-
ide as the mobile phase.
25 Compound 4:
Yield: 0.46 y (60~); melting point: 213-214C
(alpha~D = ~472 ~c = 0.05 in chloro~orm)
lH-NMR (30G MHz, CDCl~, delta): 13.22 (8, PhOH), 7.89 (dd,
H-l), 7.65 ($, H-2), 7.29 (dd, H~3), 5.35 (ddt H-7), 2.17
30 (dd, H-8a), 2.07 (dt, H-8h), 4~89 (d, H 10), 1.39
(m, ~-13a~, 1.15 (m, H-13b), 1.05 (t, H-14)~ 3.96 (~,
OMe), 0.1 and 1.18-1.33 (m, alkyl-si)~ 4.45 ts~ 9-OH)
Compound 5s
Yield: 0.27 g (35%); melting point: 103-105C
35 (alpha)D = +124 (c = 0.05 in chloroform)
, :

2~ 37
, -- 10 ~
lH-NMR ~400 MHz, CDCl3, delta): 7.72 (dd, H-l~, 7.59 (t/
H-2), 7.21 (ddl H 3), 5.34 (dd, ~ 7), 2.17 (dd, H-8a),
2.05 (dt, H-8b), 4.70 (d, H-10), 1.40 (m, H-13a), 1.31
(m, H-13b), 1.04 ~t, H-14), 3.93 and 3.91 (~, OMe), 0.1
S and 0.9-1.3 (alkyl-Si), 4.50 (æ, 9-OH)
Pxocess b):
1 g (1.42 mmol) of compound 3 were dis601ved in 4.5 ml of
acetone and 18 ml of methylene dichloride, and 4.2 g
(12.9 mmol) of cesium carbonate and 5 ml (71.5 mmol) of
methyl iodide were added with ~tirring at 4C. After a
reaction time of 3 days the reaction mixture was worked
up as described above, compound 4 (yialds 0.76 ~ (75~))
and compound 5 ~yield: 0.1 g (10~)) being isolated.
4 O-Met~yl 6,7-0-(1,1,3,3-tetrai~opropyl-di~iloxsne-1,3-
diyl)-epsilon-rhodomycinone
(Compound 6)
The title compound was prepared by the instructions for
the preparation of compound 4, ~tarting ~rom 6.03 g
(9 mmol) of compound 2, 37.49 g (30 equi~alent.) of
potassium carbonate and 56.5 ml (~00 mmol) of methyl
iodide.
Yield: 3.2 g ~52~)
Example 3
Selective deblocking of the txialkyl~ilyl protective
g~oup
4-0 ~ethyl-6,7-0-(1 t 1,3,3-tetrai~opropyldi6iloxane-1,3-
diyl)-~-rhodomycinone
(Compound 7)
2 ~ (2.8 ~mol) of compound 4 were di~601ved ~n 100 ml of
~athylane dichloride and 100 ml of msthanol, &nd 20 ml of
0.1 N hydrochloric acid were added. After stirring ~or 30
minutes ~t room temperature, the reaction mixture was
diluted with methylene dichloride and extracted by
shaking with water. The organic pha e wa~ dried by maans
. : .

o~ ~
of sodium ~ulfate and evaporated in vacuo. The r~sidue
was also filtered ~hrough 50 g of silica g~l (mobile
phase: 20.1 methylene dichloride/acetone).
Yield: 1.7 ~ (96%); melting point: 166-168C
~alpha)D = +386~ (o - 0.05 in chloroform)
~xample 4 ;~
Introduction of acyl protective groups
4-0-~ethyl-10-0-p-nitrobenzoyl-6,7-0~(1,1,3,3-tetraiso-
propyldi~iloxane-1,3-diyl)-~-rhvdomycinone
(Compound 8)
0.68g (1.05 mmol~ of compound 7 wa~ di~olved in 40 ml of
2:1 chloroform/pyridine, and 0.3 g ~1.5 e~uivalents) of
p-nitrobenzoyl chloride was added. After stirring at 0C
for 15 houxs, 10 ml of methanol were added to the reac
tion mixture. The reaction mixture was evapora~ed in
vacuo and di~tilled again with toluene. The residue was
dissolved in chloroform and washed twice with water, and
the organic phase was dried over sodium sulfate and
evaporated in vacuo~ The crude product which remained was
purified fuxther by column chromatography over 120 g of ::.
silica gel (mobile pha~e: 17:10:1 petroleum ether/methyl-
ene dichloride/acetone).
Yield: 340 m~ ~81.1g); melting point~ 114-116C
(alpha)~ = ~384D (c = 0.05 in ~hloroform)
1H-NMR (300 ~Hz, CDCl3, delta): 13.02 1~, PhOH), 7.84 (dd,
H-l~, 7.~5 (t, H-2~, 7.32 (dd, H~3), 5.51 (dd, H-7~, 2.38
(dt, H-8a), 2.07 (dd, H-8b), 6056 ~d, H-10), 1.50
(m, H-13a), 1.83 (m~ H-13b)~ 1.07 (t, H-14~, 3.98 (8, 4-
OMe), 8.08 and 8.22 (m, aryl), 0.64-1.2 (m, alkyl-Si)
10,11-Bis-~-(p-nitrobenzoyl)-4-0-methyl-6,7-0-tl,1,3,3-
tetrai~opropyldisiloxane-1,3-diyl~ ~-rhodom~cinone
(Compound 9)
0.34 g (0052g mmol) of compound 7 wa~ reacted with 0.3 g
(3 eguivalent~ of p nitrobenzoyl chloride as described
~ .
,
, ~ , , "

8~
12 -
above to give the title compound.
Yi~ld: 0.35 ~72~)
Example 5
Deblocking the tetrai~opropyldisil~xane-1,3-diyl protec-
tive group
4-O-Methyl-10-O-p-nitrobenzoyl-~-rhodomycinone
(Compound 10~
0.6 g (0.76 mmol) of ~ompound 8 was di~solved in 30 ml of
THF, and 1 ml of a 1-molar solution in THE of tetrabutyl-
ammonium fluoride was add~d at 0C. After the reactionmixture had been ~tirred for 30 minutes, 30 ml of 0.1 N
hydrochloric acid were added and the mixture was extrac-
ted twice with chloroform. The or~anic pha~e wa~ dried
over ~odi~m sulfate and ~vapora~ed in vacuo. The crude
lS product ohtained was purified by chromatography over 65 q
of silica gel (mobile pha~e: 15:1 methylene dichloride~
acetone).
Yield: 0.3~8 g (91%); meltins point: 153-155C
(alpha)D = ~275 (c = 0.02 in chlorofonm)
10,11-gis_o_(p-nitxobenzoyl)~4-O-methyl-~-rhodomycinone
~Compound 11)
0.15 g (0.15~ mmol) of compound 9 W~15 reacted with 0.2 ml
of a l-~olar ~olution in ~HF of tetrabutylamonium fluor-
ide a~ de~cribed above to give the title compound.
Yields 95.8 mg (88%)
4-O-~ethyl epsilon-rhodomycinone
(Compound 12)
The title compound wa~ prepared by the in~truction~ for
the prep~ration of compound 10, starting from 3.2 g (4.6
mmol) of compound 6.
Yield. 1.6 g (83%~; ~AB m/e = 443 ~M~Ht)
,
:~ .

- ~3 -
Example 6
Formation of glycosides of the rhodomycins with function-
alized amino-~ugar~
4-0-Methyl-10-0-p-nitrobenzoyl-7-0-(4'-0-p-nitro~enzoyl~
3'-N-trifluoroacetyl-alpha-L-daunosaminyl)-~ rhodomycin-
one
(Compound 13)
1.84 ~ ~3.36 mmol) of compound 10, 3.64 g (6~72 mmol) of
1,4-di~O-p-nitrobenzoy' 3-N-~rifluoroacetyl-alpha,~
daunosamine and 5 g of mol~cular ~ieve 4 A were ~u~p~n-
ded, with the exclu6ion of moisture, in 300 ml of a
~olvent mixture composed of lOtl chloroform/acetone. The
reaction mixture wa~ cooled to -50C, 3 ml of trimethyl-
fiilyl trifluoromethane~ulfonate were added and ~tirring
was continued ~or 4 hours at -45C. The progre~ of the
reaction wa~ monitored by thin layer chromatography
(mobile phase; 20:1, methylene dichloride/acetone). The
reac~ion mi~ture wa~ neutraliz~d (pH 7) with triethyl-
amine and was filtered. ~fter the 801vent had been
evaporated the residue wa~ purified by column chroma-
tography ~6ilica ~el; mobile phase: 20:1 methylene
dichloride~acetone).
Yield: 2~3 g (74%)
1H-NMR, HjH-COSY t300 MHz, C6H6~CDCl3 1:1, delta): 7.60 ~d~
H-l), 7.05 (tl H-2), S.58 (d, H-3)~ 5.12 (dd~ H~7)~ 2.29
(d, ~-8a), 1.90 (dd, H-8b) ~ 6.57 (6, H-10), 1.81
(m, H 13a), 1.38 (m, H-13b), 0.99 tt, H-14), 13.93 and
13.17 (8, PhOH~, 3.41 (~, OMe), 3.SO (8, 9~0H), 7.28-7.72
(~, p-N02Bz~, 5.49 (d, H-l'), 1~69 (ddd, H-2'a), 1~85
~dd, H-2'b), ~.13 (m, H 3~, 5.06 (br ~, H~4'), 4~21 (q,
H-5'), 1.00 (d, H 6'), 6.12 (d, NH)
10,11-Bis-0 (p-nitrobenzoyl)-4-0-methyl-7-0-(4'-0-p-
~itrokenzoyl~3'-N-trifluoroacetyl-alpha-L-daunosaminyl)-
~-rhodomycinone
(Compound 14)

- 14 -
The ~itle compound was prepared by ~he glyoo6idation
process for the preparation of compound 13, starting from
the aglycone compound 11 and 1,4-di~O-p-nitroben~oyl-3,N-
trifluoroacetyl-alpha,~-L-dauno~amine.
4~0-Methyl-7-0-l4'-0-p~-nitrobenzoyl-3'-N-~rifluroacetyl-
alpha-L-dauhosaminyl)-epsilon-rhodomycinone
(Compound 153
The title compound was prepared by the glyco~idation
proces~ for the preparation of the compvund 13, starting
from 4-0-methyl-epsilon-rhodomycinone (compound 12) and
1,4-di-0-p-nitrobenzoyl-3,N~trifluoroacetyl-alpha,~-L-
dauno~amine.
~xampl~ 7
Deblocking r~actions
4~0-Methyl-10-0-p-nitrobenzoyl-7-0-(3'-N-trifluoroacetyl
alpha-L-daunosami~yl)-~-rhodomycinone
(Compound 16)
0.12 g (0.13 ~mol) of compound 13 wa6 di&solved in 2 ml
of lol me~hylene dichloride/methano:l, and 0.5 ml of 0.1 N
N~OH was added. The reaction mixture was stirred for 30
minutes at room temperature. The reaction wa~ Etopped by
adding O.5 ml of 0.1 N HCl. Chloro:Eorm wa~ added to the
mi~ture and it was then extracted by washing with water.
The organic pha~e wa~ dried over ~odium ~ulfate and
evaporated in vacuo and the r86 ? d~e which re~ul ed ~as
purified by column chrom~tography (6ilica gel; 6:1
methylene dichloride/acetone).
Yield$ 0.08 g (80~), melting point: 186-188C
(alpha)D = ~700 (c = 0.~ in chloroform)
7-0-(~lpha~L~Dauno~aminy~)-4-0-methyl-~-rhodo~ycinone
(Compound 17)
O.3 g (0.32 mmol) of compound 13 wa~ dis~olved in 10 ml
of 1:1 chloroform/methanol, and 3 ml of 1 N NaOH wer~
added with ~tirring. After 2 hour~ the reaction mixture

. - ~5 -
was neutralized with 3 ml of 1 N HCl, dilu~ed with
chloroform and butanol and extracted by washing with
water. The organic phase wa~ dried over sodium ~ulfate
and evaporated in vacuo. The residue wa~ purified over
RP-18 silica gel.
Yield, 0.14 g (83%); MSs F~B m/e = 530 (~H~)
7-O-(alpha-L-Daunosaminyl)-4-O-methyl-ep~ilon-rhodomycin-
one
(Compound 18)
The title compound was prepared by the process for the
preparation of compound 16, starting from compound 15.
Example 8
~odification of the rhodomycins at the 3'-amino group
7-0-(3'-N-DLmethyl-alpha-L-daunosaminyl)-4 O-methyl~-
lS rhodomycinon~
(Compound 19)
200 mg [0.37 mmol) of compound 17 were dissolved in 20 ml
of methanol, and 0.6 ml of 37~ ~;trength formaldehyde
solution wafi added with stirring. After 142 mg of ~odium
~yanoborohydride had ~san added, the reaction mixture was
stirred for a further 3 hours. The re~ulting ~rude
product ~as purified by column chromatography (silica
gel, 3s1 chloroform/methanol).
~ield: 161 mg (78~); MS: FAB m/e = 558 (M+~+)
4 O-~ethyl-7-0-(3'~(morpholin-4-yl)-2~3,6-tri-deoxy-
~lpha-~-ly~ohexopyrano~yl~ rhodomycinone
(Compound 20)
200 mg (0.37 mmol) of compound 17 were di~olved in 20 ml
of 10:1 methanol/chloroformO and 77.2 m~ of 2,2'-hydroxy-
bis-acetaldehyde which had been freshly pr~pared from
1~4-anhydroerythritol by periodate oxidation ~ere added.
After 25 mg of ~odiuM syanoborohydride h~d been ~ddedl
the rea~tion mixture lwas ~tirred for 2 hours at room
temperature and then evaporated in vacuo. The re3idue wa~

8~3
- 16 -
purified by column chro~atography over ~P-18 silica gel.
Yields 165 mg (74%); MS: PAB m/e = 600 (M+H'~
4-O-~ethyl-(3'-morpholin-4-yl)-2,3,6~trideoxy alpha-L-
lyxohexopyrano~yl)-ep~ilon-rhodomycinone
(Compound 21)
The title compound wa~ prepared by the proees~ for the ~:
preparation of compound 20, starting from compound 18 and
2,2'-hydroxybis-acetaldehyde.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-11
Inactive: Abandon-RFE+Late fee unpaid-Correspondence sent 1996-10-21
Inactive: Adhoc Request Documented 1996-10-21
Application Not Reinstated by Deadline 1995-04-20
Time Limit for Reversal Expired 1995-04-20
Inactive: Adhoc Request Documented 1994-10-20
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 1994-10-20
Application Published (Open to Public Inspection) 1990-04-22

Abandonment History

Abandonment Date Reason Reinstatement Date
1994-10-20
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BEHRINGWERKE AKTIENGESELLSCHAFT
Past Owners on Record
CENEK KOLAR
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 1990-04-21 6 178
Abstract 1990-04-21 2 37
Drawings 1990-04-21 1 14
Representative Drawing 1990-04-21 1 2
Descriptions 1990-04-21 16 570
Fees 1992-09-30 1 31
Fees 1993-10-03 1 34
Fees 1991-10-09 1 26